The Nasdaq Composite slid more than 3% in Monday’s trading as a slate of AI-related plays, including chip darling Nvidia, ...

The tech-heavy Nasdaq Composite was down 3.6% in late-afternoon trading, while the S&P 500 fell 1.8% and the Dow Jones Industrial Average ... Wegovy and Eli Lilly's (LLY) Zepbound, had even ...

Novo's U.S. and Europe-listed stocks leapt. Shares of rival Eli Lilly (LLY) also rallied. 🔎 Affirm (AFRM): The "buy-now-pay-later" lender secured $750 million in funding from insurer Liberty ...

Eli Lilly (LLY) closed the latest trading day at $804.99, indicating a -0.39% change from the previous session's end. The stock trailed the S&P 500, which registered a daily gain of 0.92%. At the same ...

Citi analyst Geoff Meacham maintained a Buy rating on Eli Lilly & Co (LLY – Research Report) today. The company’s shares closed last Friday ...

Fresh rate cut hopes are bolstering equities from early week lows. The Dow Jones Industrial Average (DJIA) dipped into the 44,000 handle during Monday’s early overnight session, driven lower by ...

US PMI data came in more mixed than expected, to little effect. The Dow Jones Industrial Average (DJIA) churned into a soft backpedal on Friday, testing down around 200 points on a slow trading day.

The Dow Jones Industrial Average (DJIA) is a group of 30 U.S. industry leaders. It's often looked at as a proxy for the market, since its components' performance is indicative of what's happening ...

The SPDR Dow Jones Industrial Average ETF Trust (DIA) tracks the Dow Jones Industrial Average, offering exposure to 30 prominent U.S. stocks. It uses a price-weighted index method and cannot ...

outpacing Eli Lilly's own drug in early comparisons. Novo Nordisk's phase 1b/2a clinical trial results revealed that their investigational drug, amycretin, led to an average weight loss of 22% ...